Literature DB >> 19672899

Multiple sclerosis: human model for EAE?

Reinhard Hohlfeld1.   

Abstract

Concepts of the pathogenesis of MS are based on evidence from the animal model, EAE. Yet, the relationship between human MS and EAE is far from being a one-way road: many paths lead from the bedside back to animals in the laboratory.

Entities:  

Mesh：

Year:  2009        PMID： 19672899     DOI： 10.1002/eji.200939545

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN： 0014-2980            Impact factor:   5.532


  9 in total

1.  Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.

Authors:  Kerstin Berer; Marsilius Mues; Michail Koutrolos; Zakeya Al Rasbi; Marina Boziki; Caroline Johner; Hartmut Wekerle; Gurumoorthy Krishnamoorthy
Journal:  Nature       Date:  2011-10-26       Impact factor: 49.962

Review 2.  Models for Studying Myelination, Demyelination and Remyelination.

Authors:  I Osorio-Querejeta; M Sáenz-Cuesta; M Muñoz-Culla; D Otaegui
Journal:  Neuromolecular Med       Date:  2017-05-23       Impact factor: 3.843

3.  Experimental autoimmune encephalomyelitis development is aggravated by Candida albicans infection.

Authors:  Thais F C Fraga-Silva; Luiza A N Mimura; Camila M Marchetti; Fernanda Chiuso-Minicucci; Thais G D França; Sofia F G Zorzella-Pezavento; James Venturini; Maria S P Arruda; Alexandrina Sartori
Journal:  J Immunol Res       Date:  2015-04-19       Impact factor: 4.818

Review 4.  Clinical Evidence for the Microbiome in Inflammatory Diseases.

Authors:  Ann E Slingerland; Zaker Schwabkey; Diana H Wiesnoski; Robert R Jenq
Journal:  Front Immunol       Date:  2017-04-12       Impact factor: 7.561

5.  CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.

Authors:  Makbule Senel; Fatemeh Mojib-Yezdani; Ulrike Braisch; Franziska Bachhuber; Jan Lewerenz; Albert C Ludolph; Markus Otto; Hayrettin Tumani
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

Review 6.  Teriflunomide and its mechanism of action in multiple sclerosis.

Authors:  Amit Bar-Or; Andrew Pachner; Francoise Menguy-Vacheron; Johanne Kaplan; Heinz Wiendl
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

7.  Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study.

Authors:  J C Bertoglio; M Baumgartner; R Palma; E Ciampi; C Carcamo; D D Cáceres; G Acosta-Jamett; J L Hancke; R A Burgos
Journal:  BMC Neurol       Date:  2016-05-23       Impact factor: 2.474

8.  Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?

Authors:  Juliana Helena Dos Santos de Toledo; Thais Fernanda de Campos Fraga-Silva; Patrícia Aparecida Borim; Larissa Ragozo Cardoso de Oliveira; Evelyn da Silva Oliveira; Larissa Lucena Périco; Clélia Akiko Hiruma-Lima; Adriana Aparecida Lopes de Souza; Carlos Alberto Ferreira de Oliveira; Pedro de Magalhães Padilha; Marcos Felipe Pinatto-Botelho; Alcindo Aparecido Dos Santos; Alexandrina Sartori; Sofia Fernanda Gonçalves Zorzella-Pezavento
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

Review 9.  The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?

Authors:  Hannah M Kohl; Andrea R Castillo; Javier Ochoa-Repáraz
Journal:  Diseases       Date:  2020-08-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.